Related Experiment Video
Updated: Jul 7, 2026

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
Published on: November 7, 2025
[Can a standard treatment be proposed for penile cancer?]
Jean-Nicolas Cornu1, Eva Comperat, Raphaële Renard-Penna
1Services d'Urologie, l'Hôpital Pitie-Salpêtrière, Paris, France.
Objective:
Malignant tumours of the penis are rare and their management is complex. The objective of this study was to review the management and report the results based on a personal series.
Materials And Methods:
Cases of penile cancer treated in our department between 2000 and 2006 were retrospectively reviewed. The following data were recorded: mode of presentation, staging, site, pathology, TNM stage, treatment, course and survival.
Results:
Seven cases of squamous cell carcinoma of the penis were diagnosed. The mean age of the patients was 58.8 years (range: 41-74), Two precancerous lesions (Bowen's disease) and one case of Human Papilloma Virus (HPV) infection were observed. Five patients received multimodal conservative treatment and 2 patients were treated by total amputation of the penis. Four patients have died. The mean survival was 19.3 months and the 5-year specific survival was 42.8%.
Conclusion:
Cancers of the penis are aggressive tumours with a poor prognosis. Treatment decisions, which are poorly defined in these cases of rare cancers, should be based on multidisciplinary consultations.
More Related Videos
07:25A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
09:49Isolation of Adipose Derived Regenerative Cells for the Treatment of Erectile Dysfunction Following Radical Prostatectomy
Published on: December 28, 2021
Related Concept Videos
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Treatment Resistant Cancers
Treatment Resistent Cancers
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Tumor Immunotherapy